Related Experiment Video
Updated: Jan 11, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
[Cooperation between hematologists and geriatricians]
Madeleine Lefèvre1, Rachida Qabbal1, Marie-Adeline Migeon1
1Unité de coordination en oncogériatrie Paris Nord, hôpitaux Bretonneau et Saint-Louis, AP-HP, Paris, France; Service de gériatrie, hôpital Bretonneau, AP-HP, 23 rue Joseph-de-Maistre, 75018 Paris, France.
Abstract:
The increasing incidence of malignant blood disorders with advancing age, combined with the heterogeneity of the elderly population and its specific characteristics, gives oncogeriatrics an increasingly important role in hematology. Co-management by hematologists and geriatricians takes different forms depending on the underlying hematological pathology and the treatments considered, including innovative CAR-T cells. Oncogeriatric follow-up can be optimized through joint management by a geriatrician and an oncogeriatric IPA, in parallel with hematological follow-up.
More Related Videos
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
07:24A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Related Concept Videos
Drug Dosing: Geriatric Patients
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism